« previous next »

Author Question: Which of the following would be a reason for a drug company NOT to pursue expensive clinical trails ... (Read 183 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
on: Jun 22, 2018
Which of the following would be a reason for a drug company NOT to pursue expensive clinical trails with a new drug?
 
  A. The drug produces no side effects.
  B. The drug produces side effects.
  C. The therapeutic index is greater than 1.
  D. The therapeutic index is less than 1

Question 2

What kind of name is Provigil (an alerting drug)?
 
  A. chemical name
  B. generic name
  C. brand name
  D. none of the above


poopface

  • Sr. Member
  • ****
  • Posts: 339
Reply #1 on: Jun 22, 2018
Answer to Question 1

D

Answer to Question 2

C


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

future617RT

  • Hero Member
  • *****
  • Posts: 543
Reply #2 on: Jun 22, 2018
Thank you!


poopface

  • Sr. Member
  • ****
  • Posts: 339
Reply #3 on: Jun 22, 2018
Happy to help


« previous next »
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Sickle cell anemia. The clinical manifestations of sickle cell anemia result from pathologic changes Sickle cell anemia. The clinical manifestations of sickle cell anemia result from pathologic changes
Some drug labels show the USP symbol; others do not. Some drug labels show the USP symbol; others do not.
Early in the twentieth century, when malnutrition was common, companies such as this one advertised Early in the twentieth century, when malnutrition was common, companies such as this one advertised
Frequency distribution curve: interpatient variability in drug response. Frequency distribution curve: interpatient variability in drug response.
Clinically Significant Drug-Drug Interactions in Dentistry Clinically Significant Drug-Drug Interactions in Dentistry
Clinically Significant Drug-Drug Interactions in Dentistry Clinically Significant Drug-Drug Interactions in Dentistry
Video: Stroke volume - preload, sarcomere length and Frank -Starling law

For a complete list of videos, visit our video library